ArticleThoracic cancer2020

HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway.

Zhigang Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.